Division of Drug Information Twitter/Listserv Survey

Customer/Partner Service Surveys

TWITTER SURVEY 9-26-14

Division of Drug Information Twitter/Listserv Survey

OMB: 0910-0360

Document [docx]
Download: docx | pdf

Twitter Survey

  1. Please describe yourself (check all categories that apply):

  • Consumer

  • Investor

  • Healthcare Professional

  • Drug Industry

  • Media

  • Student

  • Attorney

  • Consultant

  • Clinical Researcher

  • Academia

  • Other (Please specify _____________________________________________________

  1. Please tell us how you received the latest FDA Drug Information Twitter alert.

    • Mobile device using an App

    • Mobile device using a Web browser

    • Tablet

    • Computer

  2. Do you receive mobile notifications of @FDA_Drug_Info tweets via SMS (texts)?

    • No (Please CONTINUE to Question 4)

    • Yes (Please SKIP to Question 5)

  3. I do not receive SMS (texts) of @FDA_Drug_Info tweets because (check all that apply):

    • Didn’t know tweets could be texted

    • Receiving SMS (texts) cost money

    • Prefer to check Twitter Feed on Twitter app, Web site, etc.

    • Other (Please specify)______________________________________________________

  4. What were your top three expectations for subscribing to our service(s)?

  • To receive the latest information on FDA actions related to drugs

  • To receive the latest information on drug safety and recalls

  • To receive the latest information on drug approvals

  • To receive the latest information on the drug development review process

  • To receive the latest information on FDA meetings related to drug products and Center for Drug Evaluation and Research (CDER) initiatives

  • To receive the latest information on Guidances for Industry

  • Other (Please specify ______________________________________________________

  1. Were your expectations met?

  • My expectations were EXCEEDED

  • My expectations were MET

  • My expectations were NOT MET

If your expectations were NOT MET, please explain why:

______________________________________________________________________________

  1. Using a scale of 1-5, with 5 being "Highly Effective" and 1 being "Not At All Effective", please rate the effectiveness of the current information delivered via the @FDA_Drug_Info Twitter account. Please select N/A if you were not able to access the item.

Content of the tweet 1 2 3 4 5 NA

Link accessibility 1 2 3 4 5 NA

Graphics 1 2 3 4 5 NA

Video accessibility 1 2 3 4 5 NA

Audio accessibility 1 2 3 4 5 NA

  1. Please provide us with any additional feedback relating to the @FDA_Drug_Info Twitter service, including any information you would like to receive that is currently NOT being delivered:

______________________________________________________________________________

  1. Do you currently subscribe to the Drug Information Update Listserv?

    • Yes. (Please SKIP to Question 10)

    • No. (Please CONTINUE to Question 9)

  2. I’m not subscribed to the Drug Information Update Email Listserv because (check all that apply):

    • Did not know it was available

    • Receive too many emails already

    • Prefer shorter content

    • Other:

  3. Are you open to providing follow-up information? If yes, please provide your name, email and phone number below.

Name: ________________________________________________________________________

Email Address: __________________________________________________________________

Telephone Number: ______________________________________________________________

File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorWu, Kimberly
File Modified0000-00-00
File Created2021-01-27

© 2024 OMB.report | Privacy Policy